# FOsfomycin for Male Urinary Tract Infection

> **NCT06822751** · PHASE3 · NOT_YET_RECRUITING · sponsor: **University Hospital, Rouen** · enrollment: 138 (estimated)

## Conditions studied

- Urinary Tract Infection
- Prostatitis
- Cystitis

## Interventions

- **DRUG:** Fosfomycun-trometamol

## Key facts

- **NCT ID:** NCT06822751
- **Lead sponsor:** University Hospital, Rouen
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-03
- **Primary completion:** 2029-06
- **Final completion:** 2029-06
- **Target enrollment:** 138 (ESTIMATED)
- **Last updated:** 2026-02-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06822751

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06822751, "FOsfomycin for Male Urinary Tract Infection". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT06822751. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*